☆ 4.6 Letter

Polyclonal Immunoglobulin Free Light Chain and Chronic Inflammation

MAYO CLINIC PROCEEDINGS (2012)

Journal

MAYO CLINIC PROCEEDINGS

Volume 87, Issue 10, Pages 1032-1033

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.mayocp.2012.07.012

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Pharmacology & Pharmacy

Elevated serum polyclonal immunoglobulin free light chains in patients with severe asthma

Umberto Basile, Giuseppe Santini, Cecilia Napodano, Giuseppe Macis, Krizia Pocino, Francesca Gulli, Mario Malerba, Andrew Bush, Ian M. Adcock, Paolo Montuschi

Summary: This study found that serum Ig FLC concentrations were elevated in adult males with severe asthma, and these concentrations were correlated with inflammatory outcomes. These findings suggest that serum Ig FLCs could serve as potential surrogate markers of inflammation in asthma.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Novel Biomarkers of Inflammation for the Management of Diabetes: Immunoglobulin-Free Light Chains

Akira Matsumori

Summary: Virus infection, inflammation, and genetic factors play important roles in the pathogenesis of diabetes mellitus. NF-kappa B, a family of transcription factors, is critically involved in the activation and development of B cells and is closely associated with inflammation and diabetes development. Recent findings indicate that FLC lambda, found in increased levels in the sera of diabetes mellitus patients, and the FLC lambda and kappa/lambda ratios are more specific and sensitive markers for diagnosing diabetes compared to glycated hemoglobin A1c. This suggests that FLCs may serve as promising biomarkers of inflammation related to NF-kappa B activation in diabetes. Strategies targeting NF-kappa B may be effective in preventing and treating diabetes when FLCs are modified. FLCs could also serve as surrogate endpoints in diabetes management.

BIOMEDICINES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

A New Laboratory Workflow Integrating the Free Light Chains Kappa Quotient into Routine CSF Analysis

Malte Johannes Hannich, Mohammed R. Abdullah, Kathrin Budde, Astrid Petersmann, Matthias Nauck, Alexander Dressel, Marie Suesse

Summary: This cohort study aimed to investigate whether further analysis of intrathecal inflammation can be omitted if the free light chain kappa (FLC kappa) quotient is within the reference range in the corresponding quotient diagram. The results showed that using FLC kappa-IF as a first line analysis can significantly reduce the workload of detecting immune responses in cerebrospinal fluid with high negative predictive value.

BIOMOLECULES (2022)

Add to Collection

Article Immunology

Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains

Fengping Liu, Xuefang Xu, Lin Chao, Ke Chen, Amo Shao, Danqin Sun, Yan Hong, Renjing Hu, Peng Jiang, Nan Zhang, Yonghong Xiao, Feng Yan, Ninghan Feng

Summary: This study confirmed gut dysbiosis in patients with chronic kidney disease (CKD) while investigating the impact of the microbiome on CKD and its association with serum free immunoglobulin light chain (FLC) levels. The results showed a significant difference in bacterial community between CKD patients and healthy controls, with specific bacterial enrichments and metabolic pathways predicting CKD prevalence and FLC levels. The findings indicate a crosstalk between the microbiome and immune response in CKD, highlighting the importance of gut dysbiosis in the pathogenesis of the disease.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Serum free light chain is associated with histological activity and cirrhosis in patients with chronic hepatitis B

Baode Chen, Weiwei Wang, Weiyi Xu, Lixiong Ying, Cheng Zhou, Min Zheng

Summary: The study found that serum free light chains in chronic hepatitis B patients are positively correlated with histological activity and fibrosis progression, particularly the free kappa light chain can serve as a useful predictor of liver cirrhosis.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Cell Biology

Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern

Malte Johannes Hannich, Alexander Dressel, Kathrin Budde, Astrid Petersmann, Matthias Nauck, Marie Suesse

Summary: In this study, researchers investigated the synthesis of intrathecal FLC-k in cerebrospinal fluid samples from 296 patients. They found that FLC-k synthesis can occur independently of the antibody class produced, and can help distinguish between an inflammatory process and blood contamination. This suggests that additional determination of FLC-k in quotient diagrams may aid in clinical diagnostics.

CELLS (2021)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Light Chain Deposition Disease: An Unusual Cause of Portal Hypertension

Molly Delk Plummer, Fredric Regenstein

Summary: Light chain deposition disease is a rare condition often associated with renal dysfunction, but can also affect the liver. There are few clinical case reports of liver involvement in LCDD.

HEPATOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2

Monika Gudowska-Sawczuk, Anna Moniuszko-Malinowska, Sara Paczek, Katarzyna Guziejko, Monika Chorazy, Barbara Mroczko

Summary: The aim of this study was to assess the synthesis of kappa and lambda free light chains (FLCs) in the serum of patients with COVID-19. The findings showed elevated levels of FLCs in COVID-19 patients and vaccinated individuals, and a correlation between FLCs and specific anti-SARS-CoV-2 antibodies and IL-6. Therefore, serum FLCs levels may serve as predictive markers for COVID-19.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Oncology

Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications

Linchun Xu, Yongzhong Su

Summary: Immunoglobulin light chain amyloidosis (AL) is a chronic plasma cell disorder characterized by FLC misfolding and amyloid deposition, classified into non-hyperdiploidy and hyperdiploidy subtypes with distinct treatment responses and prognostic outcomes based on cytogenetic patterns. Other genetic factors, such as specific immunoglobulin light chain germline genes and somatic mutations, also contribute to amyloid formation in AL.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

Add to Collection

Article Hematology

Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival

Julio Davila, Veronica Gonzalez-Calle, Fernando Escalante, Seila Cerda, Noemi Puig, Ramon Garcia-Sanz, Abelardo Barez, Carmen Montes, Rosa Lopez, Jose Maria Alonso, Carlos Aguilar, Aranzazu Garcia-Mateo, Jorge Labrador, Carmen Aguilera, Alfonso Garcia-Coca, Roberto Hernandez, Maria-Victoria Mateos, Enrique M. Ocio

Summary: Immunoparesis is commonly seen in newly diagnosed multiple myeloma patients. This study found that in patients ineligible for autologous stem-cell transplantation, immunoparesis was associated with poorer overall response rate, progression-free survival, and overall survival. Interestingly, some patients who recovered from immunoparesis during follow-up showed better treatment outcomes in terms of response rate, progression-free survival, and overall survival.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Add to Collection

Article Biology

Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains

Rebecca Sternke-Hoffmann, Thomas Pauly, Rasmus K. Norrild, Jan Hansen, Florian Tucholski, Magnus Haraldson Hoie, Paolo Marcatili, Mathieu Dupre, Magalie Duchateau, Martial Rey, Christian Malosse, Sabine Metzger, Amelie Boquoi, Florian Platten, Stefan U. Egelhaaf, Julia Chamot-Rooke, Roland Fenk, Luitgard Nagel-Steger, Rainer Haas, Alexander K. Buell

Summary: Researchers introduce a new systematic workflow for the biophysical characterization of multiple myeloma patient-derived immunoglobulin light chains (IgLCs) and find that in vivo aggregation behavior is unlikely to be linked to any single biophysical or biochemical parameter. They also discover that the potential to form amyloid fibrils is widespread in IgLC sequences and not limited to those sequences that form fibrils in patients.

BMC BIOLOGY (2023)

Add to Collection

Article Medical Laboratory Technology

Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers

Shin Young Yun, John Hoon Rim, Hak Park, Hyein Kang, Sang-Guk Lee, Jong-Baeck Lim

Summary: This study evaluated the clinical implications of two different methods for free light chain (FLC) quantification.The results showed that while there was good correlation between the two methods within the normal range, there was a proportional bias of up to 170% in high concentration samples, possibly due to diversity in the monomer/dimer ratio. Therefore, clinical laboratories should be aware of inter-assay variability when using different platforms for FLC measurements, especially for high concentrations of both kappa and lambda measurements. Clinical interpretations of multiple myeloma disease status may not be dramatically affected as long as the same assay is used during follow-up periods.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Article Cell Biology

Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma

Miriam I. Rosenberg, Erez Greenstein, Martin Buchkovich, Ayelet Peres, Eric Santoni-Rugiu, Lei Yang, Martin Mikl, Zalman Vaksman, David L. Gibbs, Dan Reshef, Amy Salovin, Meredith S. Irwin, Arlene Naranjo, Igor Ulitsky, Pedro A. de Alarcon, Katherine K. Matthay, Victor Weigman, Gur Yaari, Jessica A. Panzer, Nir Friedman, John M. Maris

Summary: Neuroblastoma is a lethal childhood solid tumor. Opsoclonus myoclonus ataxia syndrome (OMAS) is found in 2% of neuroblastoma patients and is characterized by cerebellar and brainstem-directed autoimmunity. In this study, OMAS-associated tumors showed greater B and T cell infiltration, poly clonal expansions, and enrichment of tertiary lymphoid structures (TLSs). The major histocompatibility complex (MHC) class II allele HLA-DOB*01:01 was significantly enriched in OMAS patients. OMAS severity scores were associated with the expression of candidate autoimmune genes. A proposed model suggests that polyclonal auto-reactive B lymphocytes act as antigen-presenting cells and drive TLS formation, supporting both anti-tumor immunity and OMAS neuropathology.

CELL REPORTS (2023)

Add to Collection

Article Medicine, General & Internal

Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment

Marie Suesse, Franz Felix Konen, Philipp Schwenkenbecher, Kathrin Budde, Matthias Nauck, Matthias Grothe, Malte Johannes Hannich, Thomas Skripuletz

Summary: This observational study investigated the effects of different disease-modifying therapies (DMT) on the humoral intrathecal immune response in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients. The results showed that highly effective DMT significantly reduced the concentrations of FLC kappa and IgG in the CSF, which may contribute to an anti-inflammatory effect in the central nervous system (CNS). There was no difference in the appearance of CSF-specific oligoclonal bands.

DIAGNOSTICS (2022)

Add to Collection

Article Immunology

Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis

Jipeng Yan, Jin Zhao, Xiaoxuan Ning, Yunlong Qin, Yan Xing, Yuwei Wang, Qing Jia, Boyong Huang, Rui Ma, Changhui Lei, Meilan Zhou, Zixian Yu, Yumeng Zhang, Wei-Feng Guo, Shiren Sun

Summary: This study demonstrates for the first time the alterations of gut microbiota in patients with AL amyloidosis and successfully establishes and validates a microbial-based diagnostic model. This provides a foundation for future research on microbe-based strategies for diagnosis and treatment in patients with AL amyloidosis.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Allergy

AllergoOncology: Microbiota in allergy and cancer-A European Academy for Allergy and Clinical Immunology position paper

Eva Untersmayr, Heather J. Bax, Christoph Bergmann, Rodolfo Bianchini, Wendy Cozen, Hannah J. Gould, Karin Hartmann, Debra H. Josephs, Francesca Levi-Schaffer, Manuel L. Penichet, Liam O'Mahony, Aurelie Poli, Frank A. Redegeld, Franziska Roth-Walter, Michelle C. Turner, Luca Vangelista, Sophia N. Karagiannis, Erika Jensen-Jarolim

ALLERGY (2019)

Add to Collection

Article Allergy

Role of Mast Cells in Shaping the Tumor Microenvironment

Daniel Elieh Ali Komi, Frank A. Redegeld

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)

Add to Collection

Article Nutrition & Dietetics

EPA and DHA have selective toxicity for PBMCs from multiple myeloma patients in a partly caspase-dependent manner

Esmaeil Mortaz, Milad Moloudizargari, Adnan Khosravi, Mohammad Hossein Asghari, Mehrnaz Movassaghi, Mohammad Varahram, Mohammad Vaezi, Frank A. Redegeld, Johan Garssen

CLINICAL NUTRITION (2020)

Add to Collection

Letter Allergy

Retinoic acid-loading of the major birch pollen allergen Bet v 1 may improve specific allergen immunotherapy: In silico, in vitro and in vivo data in BALB/c mice

Karin Hufnagl, Sheriene Moussa Afify, Nina Braun, Stefanie Wagner, Michael Wallner, Michael Hauser, Markus Wiederstein, Gabriele Gadermaier, Sabrina Wildner, Frank A. Redegeld, Bart R. Blokhuis, Gerlinde Hofstetter, Isabella Pali-Schoell, Franziska Roth-Walter, Luis F. Pacios, Erika Jensen-Jarolim

ALLERGY (2020)

Add to Collection

Article Allergy

Defining biomarkers to predict symptoms in subjects with and without allergy under natural pollen exposure

Mehmet Goekkaya, Athanasios Damialis, Thomas Nussbaumer, Isabelle Beck, Nikolaos Bounas-Pyrros, Sebastian Bezold, Marie M. Amisi, Franziska Kolek, Antonia Todorova, Adam Chaker, Lorenz Aglas, Fatima Ferreira, Frank A. Redegeld, Jens O. Brunner, Avidan U. Neumann, Claudia Traidl-Hoffmann, Stefanie Gilles

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Cell Biology

Direct Inhibition of the Allergic Effector Response by Raw Cow's Milk-An Extensive In Vitro Assessment

Suzanne Abbring, Bart R. J. Blokhuis, Julie L. Miltenburg, Kiri G. J. Romano Olmedo, Johan Garssen, Frank A. Redegeld, Betty C. A. M. van Esch

CELLS (2020)

Add to Collection

Article Multidisciplinary Sciences

Local immune response to food antigens drives meal-induced abdominal pain

Javier Aguilera-Lizarraga, Morgane Florens, Maria Francesca Viola, Piyush Jain, Lisse Decraecker, Iris Appeltans, Maria Cuende-Estevez, Naomi Fabre, Kim Van Beek, Eluisa Perna, Dafne Balemans, Nathalie Stakenborg, Stavroula Theofanous, Goele Bosmans, Stephanie U. Mondelaers, Gianluca Matteoli, Sales Ibiza Martinez, Cintya Lopez-Lopez, Josue Jaramillo-Polanco, Karel Talavera, Yeranddy A. Alpizar, Thorsten B. Feyerabend, Hans-Reimer Rodewald, Ricard Farre, Frank A. Redegeld, Jiyeon Si, Jeroen Raes, Christine Breynaert, Rik Schrijvers, Cedric Bosteels, Bart N. Lambrecht, Scott D. Boyd, Ramona A. Hoh, Deirdre Cabooter, Maxim Nelis, Patrick Augustijns, Sven Hendrix, Jessica Strid, Raf Bisschops, David E. Reed, Stephen J. Vanner, Alexandre Denadai-Souza, Mira M. Wouters, Guy E. Boeckxstaens

Summary: Research has shown that bacterial infection and toxins can trigger the production of specific dietary-antigen-specific IgE antibodies in mice, leading to increased visceral pain. Additionally, injecting food antigens into the rectosigmoid mucosa of patients with irritable bowel syndrome can induce local oedema and mast cell activation, revealing new possibilities for treating related abdominal pain disorders.

NATURE (2021)

Add to Collection

Article Cell Biology

Human milk extracellular vesicles target nodes in interconnected signalling pathways that enhance oral epithelial barrier function and dampen immune responses

Marijke Zonneveld, Martijn J. C. van Herwijnen, Marcela M. Fernandez-Gutierrez, Alberta Giovanazzi, Anne Marit de Groot, Marije Kleinjan, Toni M. M. van Capel, Alice J. A. M. Sijts, Leonie S. Taams, Johan Garssen, Esther C. de Jong, Michiel Kleerebezem, Esther N. M. Nolte-'t Hoen, Frank A. Redegeld, Marca H. M. Wauben

Summary: Maternal milk extracellular vesicles play a crucial role in supporting epithelial barrier function and modulating the immune system. Their unique proteome can target key hotspots of signaling networks in various cell types within the gastrointestinal tract.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Add to Collection

Article Allergy

Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function

Mirelle T. A. Kleuskens, Maria L. Haasnoot, Bart M. Herpers, Marleen T. J. van Ampting, Albert J. Bredenoord, Johan Garssen, Frank A. Redegeld, Betty C. A. M. van Esch

Summary: The study investigated the effects of SCFAs acetate, propionate, and butyrate on the esophageal barrier function in EoE, finding that butyrate and propionate can restore the barrier function of esophageal epithelial cells after inflammatory insult. This suggests that these nutraceuticals may have therapeutic benefits in managing EoE.

ALLERGY (2022)

Add to Collection

Article Cell Biology

Omega-3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation

Jing Chen, Esther A. Zaal, Celia R. Berkers, Rob Ruijtenbeek, Johan Garssen, Frank A. Redegeld

Summary: The study demonstrates that pretreating MM cells with DHA/EPA before bortezomib significantly enhances chemosensitivity by decreasing GSH levels and altering metabolism, highlighting the role of GSH degradation in overcoming drug resistance. RNA-seq results suggest the NRF2-ATF3/4-CHAC1 signaling pathway as central in GSH degradation and indicate potential connections to various pathways contributing to the tumor suppressive effect. The findings implicate GSH degradation as a promising therapeutic target in MM and provide new insights into combating bortezomib resistance.

CELLS (2021)

Add to Collection

Article Allergy

Micronutritional supplementation with a holoBLG-based FSMP (food for special medical purposes)-lozenge alleviates allergic symptoms in BALB/c mice: Imitating the protective farm effect

Sheriene Moussa Afify, Andreas Regner, Luis F. Pacios, Bart R. Blokhuis, Sebastian A. Jensen, Frank A. Redegeld, Isabella Pali-Schoell, Karin Hufnagl, Rodolfo Bianchini, Sonja Guethoff, Matthias F. Kramer, Alessandro Fiocchi, Zdenek Dvorak, Erika Jensen-Jarolim, Franziska Roth-Walter

Summary: The lozenge formulated with catechin-iron complexes effectively masked IgE binding in milk-allergic children and reduced immune reactivity in mice and allergic subjects. By targeting antigen presenting cells, the lozenge dampened immune activation in a non-specific manner, providing immune resilience against allergic symptoms.

CLINICAL AND EXPERIMENTAL ALLERGY (2022)

Add to Collection

Editorial Material Allergy

Selenomethionine attenuates allergic effector responses in human primary mast cells

Xiaoli Zhao, Bart. R. J. Blokhuis, Frank. A. Redegeld, Iris Chang, Diane Dunham, Hongbing Chen, Kari Nadeau, Johan Garssen, Leon M. J. Knippels, Astrid Hogenkamp

ALLERGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Esterified derivatives of DHA and EPA increase bortezomib cytotoxicity in human multiple myeloma cells

Jing Chen, Rob Ruijtenbeek, Johan Garssen, Frank A. Redegeld

Summary: This study found that ethyl ester-DHA/EPA can induce stronger cytotoxicity in MM cells, even in resistant cells. Pretreating MM cells with ethyl ester-DHA/EPA can enhance the cytotoxicity of bortezomib. Additionally, treatment with ethyl ester-DHA/EPA resulted in increased intracellular ROS levels, reflecting enhanced oxidative stress in treated cells.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes

Natasa Vukovic, Samer Halabi, Joan Salvador Russo-Cabrera, Bart Blokhuis, Pedro Berraondo, Frank A. M. Redegeld, Dietmar M. W. Zaiss

Summary: Bispecific antibodies (bsAbs) targeting two different antigens offer a higher level of specificity and improved clinical efficacy in cancer therapy compared to monoclonal antibodies (mAbs). We successfully developed dual tumor-associated antigen-targeting bispecific human IgE antibodies to combine the promising potential of IgE molecules with increased target selectivity. These IgE bsAbs demonstrate potent antibody-dependent cell toxicity and have significant clinical application potential.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Add to Collection

Meeting Abstract Gastroenterology & Hepatology

ACUTE VISIBLE MUCOSAL REACTIONS OF THE ESOPHAGUS AFTER LOCAL ALLERGEN PROVOCATION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

Maria Haasnoot, Mirelle Kleuskens, Ingrid Terreehorst, Jaap H. Akkerdaas, Ronald van Ree, Frank A. Redegeld, Betty C. Van Esch, Arjan Bredenoord

GASTROENTEROLOGY (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.